PE000031
Jump to navigation
Jump to search
| Name | R.LEPVHLQLQCMSQEQLAQVAAN[H5N4S2]ATK.E |
|---|---|
| Sequence | LEPVHLQLQCMSQEQLAQVAANATK |
| Glycans(s) | H5N4S2 (N22) |
| Mod(s) | 57.021 (C10) |
| Molecular Weight | 5029.194 |
| Norm. RT | 92.947 |
| Protein | PGLYRP2 (Q96PD5) |
Samples
DDA Transition Groups
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Inst. | Sample | Transitions | |
|---|---|---|---|---|---|---|---|---|
| TG002536 | 49.053 | 49.172 | 92.134 | 1,253.807 | 4 | Orbitrap | Human Serum | 6 |
| TG000760 | 49.140 | 48.900 | 92.947 | 1,253.807 | 4 | Orbitrap | Human Serum | 10 |
| TG002769 | 48.976 | 48.868 | 93.351 | 1,253.807 | 4 | Orbitrap | Human Serum | 6 |
| TG000616 | 49.434 | 49.100 | 93.427 | 1,253.807 | 4 | Orbitrap | Human Serum | 9 |
| TG003265 | 50.221 | 50.093 | 91.718 | 1,671.406 | 3 | Orbitrap | Human Serum | 6 |
DIA Transition Groups
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Inst. | Sample | Intensity | |
|---|---|---|---|---|---|---|---|---|
| TG008338 | 38.484 | 38.484 | 93.203 | 1,253.807 | 4 | TripleTOF | Human Serum | 57,509.4 |
| TG008646 | 38.531 | 38.531 | 91.335 | 1,253.807 | 4 | TripleTOF | Human Serum | 56,408.9 |
| TG008043 | 38.095 | 38.095 | 89.621 | 1,253.807 | 4 | TripleTOF | Human Serum | 50,012.3 |
| TG008939 | 37.809 | 37.809 | 91.923 | 1,253.807 | 4 | TripleTOF | Human Serum | 48,558.4 |
| TG009261 | 38.640 | 38.640 | 92.991 | 1,253.807 | 4 | TripleTOF | Human Serum | 45,067.5 |
| TG009573 | 37.923 | 37.923 | 90.740 | 1,253.807 | 4 | TripleTOF | Human Serum | 30,208.6 |
| TG004594 | 35.446 | 35.446 | 89.466 | 1,253.807 | 4 | TripleTOF | Human Serum | 151.291 |